MedPath

LACTULOSE

LACTULOSE SOLUTION, USP

Approved
Approval ID

7016bd71-c667-46fc-8c56-5023682e8bbe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 19, 2020

Manufacturers
FDA

VistaPharm, Inc.

DUNS: 116743084

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LACTULOSE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66689-039
Application NumberANDA074138
Product Classification
M
Marketing Category
C73584
G
Generic Name
LACTULOSE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 19, 2020
FDA Product Classification

INGREDIENTS (4)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
LACTULOSEActive
Quantity: 10 g in 15 mL
Code: 9U7D5QH5AE
Classification: ACTIB
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT

LACTULOSE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66689-038
Application NumberANDA074138
Product Classification
M
Marketing Category
C73584
G
Generic Name
LACTULOSE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 19, 2020
FDA Product Classification

INGREDIENTS (4)

LACTULOSEActive
Quantity: 20 g in 30 mL
Code: 9U7D5QH5AE
Classification: ACTIB
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACTULOSE - FDA Drug Approval Details